Related Experiment Videos
Enzymatic reduction of beta-ketonitrosamines
Carcinogenesis
|November 1, 1983
Summary
Hepatic and pancreatic enzymes in hamsters and rats metabolize N-nitrosobis(2-oxopropyl)amine (BOP) and N-nitroso(2-oxopropyl)propylamine (NOPPA). Pancreatic reduction of BOP is unlikely to cause cancer, despite species-specific differences in enzyme activity.
Area of Science:
- Biochemistry
- Toxicology
- Carcinogenesis
Background:
- N-nitrosobis(2-oxopropyl)amine) (BOP) and N-nitroso(2-oxopropyl)propylamine (NOPPA) are nitrosamines with carcinogenic potential.
- Species-specific differences in cancer induction by BOP suggest variations in metabolic pathways.
Purpose of the Study:
- To investigate the reduction of BOP and NOPPA by hepatic and pancreatic enzymes in Syrian golden hamsters and Sprague-Dawley rats.
- To determine the role of pancreatic reduction in BOP-induced pancreatic cancer.
Main Methods:
- Incubation of hepatic and pancreatic cytosol and microsomes with BOP and NOPPA.
- Assay of reductase activity using NADH and NADPH as cofactors.
- Comparison of enzyme activity between species and tissues.
Main Results:
- Both hepatic and pancreatic fractions reduced BOP and NOPPA, with activity dependent on the fraction and cofactor.
- Hamster hepatic fractions showed higher activity than rat fractions; BOP was a better substrate than NOPPA.
- Pancreatic cytosol exhibited reductase activity, with hamster cytosol utilizing both NADH and NADPH, while rat cytosol required NADPH.
- BOP was the preferred substrate for pancreatic enzymes, with similar activity in rats and hamsters when NADPH was present.
Conclusions:
- Hepatic and pancreatic enzymes contribute to the metabolism of BOP and NOPPA in both rats and hamsters.
- The observed species-specific differences in enzyme activity may influence carcinogenicity.
- Pancreatic reduction of BOP is unlikely to be a major factor in the species-specific induction of pancreatic cancer by BOP.